The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the TNXP is 1.77%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional ownership for the TNXP is 4.90%.
Insider trading is the buying or selling of any publicly traded company’s stock and this can be done by someone who has non-public, material information about that TNXP. Insider trading can be illegal or legal depending on when the insider makes the trade. It is illegal when the material information is still non-public. The insider transactions of the company (6-month change in insider ownerships) for the Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is 38.86%.
Institutional ownership is the amount of a Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the TNXP is -50.91%.
a Healthcare sector firm, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock edged up 7.30% on Monday and when day-trade ended the stock finally concluded at $1.47 and number of shares that changed hands during the day are 304200. The number of shares TNXP stock currently held by all its shareholders are 6.06 and floated shares, the number of shares are available for trading in an open market on last trading day are 5.95. The average volume of shares for 3 months is 631.51 and TNXP stock value has moved between $1.25 – 49 in last one year.
The Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)’s latest earnings date is 8/12/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. The valuable gross margin for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock has gained -33.18% in 2019 to date.
U.S. traded shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)’s monthly stock performance is -11.98%, the quarterly performance is -41.43%, the half year performance is calculated as -25.00%. The yearly performance of TNXP is -96.79%.
The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) weekly volatility is measured as 10.15% and monthly volatility measured as 7.61%.
Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. TNXP return on assets is -141.90%, the return on equity (ROE) of the Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is -161.40%.
The price to book ratio is 0.40, price to cash per share ration is 0.54.
Analysts mean target price for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is $4.83 while analysts mean recommendation is 2.00. The current share price indicates that stock is -96.94% away from its one year high and is moving 17.60% ahead of its 52-week low. TNXP’s distance from 20 day simple moving average is -4.76% and distance from 50-Day simple moving average is -18.70%.